Physician
Jayashree Sinha MD PC
Jayashree Sinha MD PC was paid $2.23M by Medicaid between Jan 2018 and Dec 2024, across 46 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 23% of everything it billed.
33Billing provider infoJAYASHREE SINHA MD PC
CLOVIS, NM 88101
CLOVIS, NM 88101
33aNPI1073702635assigned 10/19/2007
33bProvider typeRheumatology Physician
28Total paid$2.23M
24GClaims53,555
24DCodes billed46
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rheumatology Physician providers in New Mexico
Rank by total paid#1 of 6
Median peer was paid$24K
This provider vs. median92×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,912 | $323K | |
| 2019 | 10,462 | $484K | |
| 2020 | 7,942 | $308K | |
| 2021 | 10,131 | $377K | |
| 2022 | 7,682 | $271K | |
| 2023 | 6,572 | $269K | |
| 2024incomplete | 3,854 | $199K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 8,002 | 7,627 | $507K |
| 76881 | 15% | 4,582 | 2,266 | $335K | |
| J3262 | Injection, tocilizumab, 1 mg | 12% | 377 | 268 | $267K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.7% | 4,889 | 4,460 | $193K |
| 86235 | 7.1% | 1,287 | 1,284 | $158K | |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7.0% | 131 | 109 | $157K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 5.6% | 2,519 | 2,176 | $125K |
| 99443 | 2.8% | 694 | 661 | $63K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.9% | 378 | 373 | $43K |
| 86480 | 1.7% | 630 | 628 | $38K | |
| 86481 | 1.6% | 362 | 362 | $36K | |
| 99442 | 1.4% | 494 | 467 | $32K |
34 more codes
| 80053 | Comprehensive metabolic panel | 1.3% | 2,602 | $28K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 2,897 | $23K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 3,310 | $19K |
| 86225 | <1% | 1,284 | $17K | |
| 86800 | <1% | 1,060 | $16K | |
| 86200 | <1% | 1,274 | $16K | |
| 86226 | <1% | 1,290 | $15K | |
| 86376 | <1% | 1,061 | $15K | |
| 83516 | <1% | 656 | $15K | |
| 86140 | <1% | 2,619 | $13K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,391 | $13K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 751 | $12K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 732 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 909 | $11K |
| 76882 | <1% | 263 | $10K | |
| 85652 | <1% | 3,379 | $9K | |
| 76942 | <1% | 207 | $8K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 155 | $8K |
| 96415 | <1% | 162 | $6K | |
| 86431 | <1% | 654 | $4K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 41 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 67 | $1K |
| 90674 | <1% | 45 | $895.62 | |
| 90756 | <1% | 62 | $826.45 | |
| 20552 | <1% | 13 | $614.79 | |
| 99305 | <1% | 27 | $596.56 | |
| 20611 | <1% | 14 | $571.47 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 57 | $423.82 |
| 96401 | <1% | 24 | $256.11 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 64 | $235.58 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 18 | $235.27 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 40 | $95.55 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 17 | $67.59 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 65 | $59.05 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSINHA, JAYASHREE (OWNER)